Sentence ID	Sentence	isValid
345	The aim of this study was to investigate the effects of hCG, hCG plus PROTEIN1 and PROTEIN2 on [3H] PROTEIN (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts	FALSE
346	The aim of this study was to investigate the effects of hCG, hCG plus PROTEIN and PROTEIN1 on [3H] PROTEIN2 (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts	TRUE
347	The aim of this study was to investigate the effects of hCG, hCG plus PROTEIN1 and PROTEIN on [3H] PROTEIN2 (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts	TRUE
348	The highest production of total PROTEIN1 (d.p.m.) was found in cells from ovariectomized gilts given in vivo estradiol benzoate and progesterone for five consecutive days and treated with 1000 mU hCG and 100 mU hCG plus 1 microM PROTEIN2 (984 +/- 84 and 1063 +/- 131 vs 314 +/- 36, respectively)	TRUE
349	There was also a very significant increase of PROTEIN1 after the addition of 1000 mU hCG (p < 0.001) and PROTEIN2 and PROTEIN when 1000 mU hCG plus PROTEIN were added (p < 0.001 and p < 0.01, respectively)	FALSE
350	There was also a very significant increase of PROTEIN after the addition of 1000 mU hCG (p < 0.001) and PROTEIN1 and PROTEIN2 when 1000 mU hCG plus PROTEIN were added (p < 0.001 and p < 0.01, respectively)	FALSE
351	There was also a very significant increase of PROTEIN after the addition of 1000 mU hCG (p < 0.001) and PROTEIN1 and PROTEIN when 1000 mU hCG plus PROTEIN2 were added (p < 0.001 and p < 0.01, respectively)	TRUE
352	There was also a very significant increase of PROTEIN1 after the addition of 1000 mU hCG (p < 0.001) and PROTEIN and PROTEIN2 when 1000 mU hCG plus PROTEIN were added (p < 0.001 and p < 0.01, respectively)	FALSE
353	There was also a very significant increase of PROTEIN1 after the addition of 1000 mU hCG (p < 0.001) and PROTEIN and PROTEIN when 1000 mU hCG plus PROTEIN2 were added (p < 0.001 and p < 0.01, respectively)	TRUE
354	There was also a very significant increase of PROTEIN after the addition of 1000 mU hCG (p < 0.001) and PROTEIN and PROTEIN1 when 1000 mU hCG plus PROTEIN2 were added (p < 0.001 and p < 0.01, respectively)	TRUE
355	Only PROTEIN1 alone increased the formation of PROTEIN2 in cells from ovariectomized pigs treated with estradiol in vivo (p < 0.01)	TRUE
356	The highest dose of hCG plus The highest dose of hCG plus PROTEIN1 provoked accumulation of total [3H] PROTEIN2 (p < 0.05) 53% over the basal level on days 21/1 of the estrous cycle	TRUE
357	The present study demonstrates that hCG and PROTEIN1 can increase the accumulation of PROTEIN2 in porcine myometrial cells	TRUE
358	In HVSMC both PROTEIN1 and AVP increased PROTEIN (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for PROTEIN2 than AVP	FALSE
359	In HVSMC both PROTEIN1 and AVP increased PROTEIN2 (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for PROTEIN than AVP	TRUE
360	In HVSMC both PROTEIN and AVP increased PROTEIN1 (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for PROTEIN2 than AVP	FALSE
361	Gamma-aminobutyric acid mediation of the inhibitory effect of nitric oxide on the arginine vasopressin and PROTEIN1 responses to PROTEIN2 induced hypoglycemia	TRUE
362	Previous studies have demonstrated that the nitric oxide (NO) synthase inhibitor L-NAME exerts positive effects on the arginine vasopressin (AVP) and PROTEIN1 (OT) responses to PROTEIN2 induced hypoglycemia, suggesting inhibitory actions of NO	TRUE
363	AVP and PROTEIN1 secretory patterns during PROTEIN2 (0.15 IU/kg, i.v.)-tolerance tests (ITT) were examined in seven normal male subjects with (experimental tests) and without (control test) concomitant treatment with L-NAME (40 micrograms/kg injected plus 50 micrograms/kg infused, i.v.), the GABAergic agent sodium valproate (600 mg in three divided doses orally) or the combination of L-NAME and sodium valproate	FALSE
364	 PROTEIN1 induced hypoglycemia increased by 2-fold (peak vs. baseline) plasma AVP and PROTEIN2 levels	TRUE
365	These data indicate a GABAergic mediation of the inhibitory modulation by NO of the AVP and PROTEIN1 responses to PROTEIN2 induced hypoglycemia	TRUE
366	Association of the insulin receptor with PROTEIN1 (PLCgamma) in 3T3-L1 adipocytes suggests a role for PROTEIN2 in metabolic signaling by PROTEIN 	FALSE
367	Association of the insulin receptor with PROTEIN (PLCgamma) in 3T3-L1 adipocytes suggests a role for PROTEIN1 in metabolic signaling by PROTEIN2 	TRUE
368	Association of the insulin receptor with PROTEIN1 (PLCgamma) in 3T3-L1 adipocytes suggests a role for PROTEIN in metabolic signaling by PROTEIN2 	FALSE
369	To determine the functional significance of the interaction of PROTEIN and the IR, we used a specific inhibitor of PROTEIN U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN1 to block PROTEIN2 stimulated GLUT4 translocation	FALSE
370	To determine the functional significance of the interaction of PROTEIN1 and the IR, we used a specific inhibitor of PROTEIN U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN2 to block PROTEIN stimulated GLUT4 translocation	FALSE
371	To determine the functional significance of the interaction of PROTEIN and the IR, we used a specific inhibitor of PROTEIN1 U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN2 to block PROTEIN stimulated GLUT4 translocation	FALSE
372	To determine the functional significance of the interaction of PROTEIN1 and the IR, we used a specific inhibitor of PROTEIN U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN to block PROTEIN2 stimulated GLUT4 translocation	FALSE
373	To determine the functional significance of the interaction of PROTEIN and the IR, we used a specific inhibitor of PROTEIN1 U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN to block PROTEIN2 stimulated GLUT4 translocation	FALSE
374	To determine the functional significance of the interaction of PROTEIN1 and the IR, we used a specific inhibitor of PROTEIN2 U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PROTEIN to block PROTEIN stimulated GLUT4 translocation	FALSE
375	Although osmotic stimuli cause an increase in nitric oxide synthase (NOS) activity as well as synthesis of AVP and PROTEIN1 in the paraventricular (PVN) and supraoptic nuclei (SON), it is not known whether NOS activity in the hypothalamus changes in the diabetic patients who have plasma hyperosmolality with hyperglycaemia caused by PROTEIN2 deficiency	FALSE
376	Three weeks after administration of STZ, the diabetic rats were subcutaneously treated with PROTEIN1 for 1 week, which resulted in significant suppression of the induction of nNOS, AVP and PROTEIN2 gene expression in the PVN and SON	TRUE
377	Downregulation of PROTEIN1 mRNA in white adipose tissue and PROTEIN mRNA in skeletal muscle during the early stages of PROTEIN2 treatment	TRUE
378	Downregulation of PROTEIN1 mRNA in white adipose tissue and PROTEIN2 mRNA in skeletal muscle during the early stages of PROTEIN treatment	FALSE
379	Downregulation of PROTEIN mRNA in white adipose tissue and PROTEIN1 mRNA in skeletal muscle during the early stages of PROTEIN2 treatment	TRUE
380	 PROTEIN1 by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in PROTEIN2 mRNA in WAT (47-52%) and PROTEIN mRNA in SM (33-37%)	TRUE
381	 PROTEIN by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in PROTEIN1 mRNA in WAT (47-52%) and PROTEIN2 mRNA in SM (33-37%)	FALSE
382	 PROTEIN1 by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in PROTEIN mRNA in WAT (47-52%) and PROTEIN2 mRNA in SM (33-37%)	TRUE
383	Denervation suppressed mRNA levels for PROTEIN1 (49%), PROTEIN (36%), and COX-IV (59%) and eliminated the acute response to PROTEIN2 in SM	FALSE
384	Denervation suppressed mRNA levels for PROTEIN1 (49%), PROTEIN2 (36%), and COX-IV (59%) and eliminated the acute response to PROTEIN in SM	FALSE
385	Denervation suppressed mRNA levels for PROTEIN (49%), PROTEIN1 (36%), and COX-IV (59%) and eliminated the acute response to PROTEIN2 in SM	FALSE
386	Furthermore, our 14C-acetate-labeling studies showed a 50% reduction in PROTEIN1 synthesis in the presence of either PROTEIN2 which could account for the reduction in net apoB secretion caused by incubation with these compounds	TRUE
387	The effects of the fluorinated analogues were evaluated on inhibition of cress seed germination and inhibition of PROTEIN1 inducible PROTEIN2 induction in embryoless barley half-seeds	TRUE
388	(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited PROTEIN1 inducible PROTEIN induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of PROTEIN2 production	FALSE
389	(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited PROTEIN inducible PROTEIN1 induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of PROTEIN2 production	FALSE
390	(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited PROTEIN1 inducible PROTEIN2 induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of PROTEIN production	TRUE
391	Isolation and characterization of gibbestatin B, an inhibitor of PROTEIN1 induced expression of PROTEIN2 and gibbestatin C from streptomycetaes	TRUE
392	 PROTEIN1 and PROTEIN2 (1 and 2) mRNA levels were determined by reverse transcription-polymerase chain reaction (RT-PCR) methodology in adipose tissue and gastrocnemius muscle	FALSE
393	A negative correlation between WAT O2 consumption and PROTEIN1 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN2 expression, as well as for plasma PROTEIN and WAT PROTEIN expression	FALSE
394	A negative correlation between WAT O2 consumption and PROTEIN expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN1 expression, as well as for plasma PROTEIN2 and WAT PROTEIN expression	FALSE
395	A negative correlation between WAT O2 consumption and PROTEIN expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN1 expression, as well as for plasma PROTEIN and WAT PROTEIN2 expression	FALSE
396	A negative correlation between WAT O2 consumption and PROTEIN1 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN expression, as well as for plasma PROTEIN2 and WAT PROTEIN expression	FALSE
397	A negative correlation between WAT O2 consumption and PROTEIN1 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN expression, as well as for plasma PROTEIN and WAT PROTEIN2 expression	FALSE
398	A negative correlation between WAT O2 consumption and PROTEIN expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle PROTEIN expression, as well as for plasma PROTEIN1 and WAT PROTEIN2 expression	FALSE
399	The aims of this study were: (1) to assess the effects of maternal undernutrition during pregnancy on adult offspring with regard to growth, body composition and plasma levels of glucose, PROTEIN1 and corticosterone, and (2) to investigate whether PROTEIN2 treatment early in life could ameliorate the adverse effects of food restriction in utero	FALSE
400	 PROTEIN1 (PLC) activity was investigated by stimulation of membrane preparations obtained from PROTEIN2 (beta-TC3)-, somatostatin (Rin 1027-B2)-, and glucagon (INR1-G9)-producing pancreatic cell lines using the non-hydrolyzable GTP analogue GTPgammaS alone, the C-terminal octapeptide cholecystokinin (CCK-8), or gastrin	FALSE
401	Therefore, it was examined whether stimulation of Swiss 3T3 cells with PROTEIN1 causes changes in the subcellular distribution of EGF receptors and PROTEIN2 that could potentially explain the observed synergy or costimulation.	TRUE
402	However, both EGF and PROTEIN stimulated the accumulation of PROTEIN1 at the actin arc, which was coincident with the EGF receptor in the case of PROTEIN2 stimulated cells.	FALSE
403	However, both EGF and PROTEIN1 stimulated the accumulation of PROTEIN at the actin arc, which was coincident with the EGF receptor in the case of PROTEIN2 stimulated cells.	FALSE
404	However, both EGF and PROTEIN1 stimulated the accumulation of PROTEIN2 at the actin arc, which was coincident with the EGF receptor in the case of PROTEIN stimulated cells.	TRUE
405	Therefore, it is suggested that the PROTEIN1 induced coclustering of the EGF receptor with PROTEIN2 at the actin arc may allow for greater efficiency of signal transduction, resulting in the synergy observed for these two hormones in stimulation of DNA synthesis.	TRUE
406	For example, PROTEIN1 suppresses PROTEIN2 (NPY) expression in the arcuate nucleus	TRUE
407	Plasma insulin, cholecystokinin, galanin, PROTEIN1 and PROTEIN2 levels in obese women with and without type 2 diabetes mellitus	FALSE
408	Experimental studies provided evidences that PROTEIN1 cholecystokinin (CCK), galanin (GAL), PROTEIN2 (NPY) and insulin are involved in feeding behaviour	FALSE
409	Plasma concentrations of FSH, PROTEIN1 CCK, GAL, PROTEIN2 and insulin were determined using commercial RIA kits	FALSE
410	Our results, ie higher mean plasma PROTEIN1 levels in postmenopausal diabetic women and positive correlation of CCK with PROTEIN2 and insulin, may suggest the role of these neuropeptides in metabolic disorders leading to type 2 diabetes mellitus	FALSE
411	Finally, recent evidences suggest that melanocortins could be involved in mediating the effects of PROTEIN1 and in controlling the expression of PROTEIN2 (NPY)	FALSE
412	Hesperidin, the most important PROTEIN1 of Citrus sp., significantly increases HDL and lowers PROTEIN2 LDL, total lipid and triglyceride plasma levels in normolipidemic rats and in rats with diet- and triton-induced hyperlipidemia	TRUE
413	 PROTEIN1 (OT) and vasopressin (AVP) stimulate PROTEIN2 and glucagon release from the pancreas, and evoke PROTEIN secretion from the rat insulinoma cell line, RINm5F	TRUE
414	 PROTEIN (OT) and vasopressin (AVP) stimulate PROTEIN1 and glucagon release from the pancreas, and evoke PROTEIN2 secretion from the rat insulinoma cell line, RINm5F	FALSE
415	 PROTEIN1 (OT) and vasopressin (AVP) stimulate PROTEIN and glucagon release from the pancreas, and evoke PROTEIN2 secretion from the rat insulinoma cell line, RINm5F	TRUE
416	Effects of PROTEIN1 arginine-vasopressin and lysine-vasopressin on PROTEIN2 and glucagon secretion in sheep	TRUE
417	The effects of the posterior-pituitary peptides PROTEIN1 (OT), arginine-vasopressin (AVP) and lysine-vasopressin (LVP) on PROTEIN2 and glucagon secretion were examined in adult sheep	TRUE
418	The maximal PROTEIN responses induced by PROTEIN1 and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN2 were higher than those of PROTEIN 	FALSE
419	The maximal PROTEIN1 responses induced by PROTEIN2 and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN were higher than those of PROTEIN 	TRUE
420	The maximal PROTEIN responses induced by PROTEIN1 and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN were higher than those of PROTEIN2 	FALSE
421	The maximal PROTEIN1 responses induced by PROTEIN and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN2 were higher than those of PROTEIN 	FALSE
422	The maximal PROTEIN responses induced by PROTEIN and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN1 were higher than those of PROTEIN2 	TRUE
423	The maximal PROTEIN1 responses induced by PROTEIN and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma PROTEIN were higher than those of PROTEIN2 	FALSE
424	Interleukin-1 beta inhibits PROTEIN1 and PROTEIN2 secretion at sites apart from KATP channel	FALSE
425	Surprisingly, however, when islets were depolarized directly using either of two agonists, glyburide (which does not act via generation of purine nucleotides) or 40 mM K+ (which acts distal to KATP channel), PROTEIN1 and PROTEIN2 secretion were again obliterated by IL-1 beta	FALSE
426	These data (together with the finding that IL-1 beta inhibited Ca(2+)-induced PROTEIN1 release) suggest that, in addition to its effects on ATP synthesis and thereby on the KATP channel, IL-1 beta has at least two undescribed, distal effects to block both PROTEIN2 as well as Ca(2+)-induced exocytosis	FALSE
